Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Venus Concept Inc. Director's Dealing 2020

Mar 20, 2020

35449_dirs_2020-03-20_d3393422-a2ef-4d7d-8f34-9e3e5cf0216c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Venus Concept Inc. (VERO)
CIK: 0001409269
Period of Report: 2020-03-18

Reporting Person: BARRY RICHARD SCOTT (Director, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-03-18 Series A Preferred Stock $ P 519114.7 Acquired Common Stock (5191147) Indirect
2020-03-18 Warrant (right to buy) $3.50 P 3893360 Acquired Common Stock (3893360) Indirect
2020-03-18 Series A Preferred Stock $ P 20885.3 Acquired Common Stock (208853) Indirect
2020-03-18 Warrant (right to buy) $3.50 P 156640 Acquired Common Stock (156640) Indirect

Footnotes

F1: Each share of Series A Preferred Stock converts into ten shares of Common Stock for no additional consideration.

F2: The Series A Preferred Stock is convertible into common stock at any time, upon approval of the stockholders, and has no expiration date.

F3: These securities were purchased from the Issuer at a purchase price of $2.50 per unit (consisting of one-tenth of one share of Series A Preferred Stock and 0.75 of a Warrant, with each whole Warrant exercisable for one share of Common Stock, at an exercise price of $3.50 per share).

F4: Held by EW Healthcare Partners L.P. ("EWHP"). Essex Woodlands Fund IX-GP, L.P. ("EW Fund IX GP") is the general partner of EWHP and EWHP-A (as defined below). Essex Woodlands IX, LLC ("Essex IX General Partner") is the general partner of Essex IX Fund GP. Martin P. Sutter, R. Scott Barry, Ronald W. Eastman, Petri Vainio and Steve Wiggins are each a Manager of Essex IX General Partner (the "Managers"). Each of the Managers may be deemed to exercise shared voting and investment power with respect to such shares. Each of EW Fund IX GP, Essex IX General Partner and the Managers, including Mr. Barry who is a member of the Issuer's board of directors, disclaims beneficial ownership of the shares held by EWHP and EWHP-A, except to the extent of any pecuniary interests therein.

F5: The Warrants have a five-year term and are exercisable beginning 181 days after their issue date.

F6: Held by EW Healthcare Partners-A L.P. ("EWHP-A").